Latest News

Researchers discover origin of resistance to lung cancer




For treating cancer, drugs based on molecules known as tyrosine kinase inhibitors are sometimes used. One such tyrosine kinase inhibitor, called osimertinib, has been used to treat EGFR-mutated lung cancer with a certain degree of efficacy.

Source link




Related posts

Heart Patients Pay the Price When Nearby Pharmacy Closes

Newsemia

Medical News Today: How to burn fat if you cannot workout

Newsemia

Vaccine drama on display in California’s Capitol

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy